Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-26T03:37:28.532Z Has data issue: false hasContentIssue false
  • English
  • Français

Controlled Drug Delivery to the Joints by Enzymatically Degradable Microspheres

Published online by Cambridge University Press:  15 February 2011

Kimberly E. Brown ,
Wen Shao ,
Joan Bathon  and
Kam W. Leong
Kimberly E. Brown
Affiliation:
Departments of Biomedical Engineering, The Johns Hopkins University, School of Medicine, Baltimore, MD 21218
Wen Shao
Affiliation:
Departments of Biomedical Engineering, The Johns Hopkins University, School of Medicine, Baltimore, MD 21218
Joan Bathon
Affiliation:
MedicineThe Johns Hopkins University, School of Medicine, Baltimore, MD 21218
Kam W. Leong
Affiliation:
Departments of Biomedical Engineering, The Johns Hopkins University, School of Medicine, Baltimore, MD 21218
Get access

Abstract

An intra-articular polymeric controlled release system was developed that is tailored to, and responsive to, the intensity of joint inflammation. Microspheres composed of the naturally occurring polyelectrolytes, gelatin and chondroitin sulfate, were synthesized by complex coacervation and the kinetics of release of encapsulated 14C-catalase was evaluated in vitro in the presence of inflammatory and non-inflammatory human joint fluids. The relative activity of gelatinase, a metalloprotease enzyme, was quantified in each of the joint fluids. Rate of degradation of the microspheres, and consequent release of 14C-catalase, was found to parallel the relative gelatinase activities in the joint fluids. Furthermore, various methods of crosslinking were found to affect the kinetics of microsphere degradation in the fluids. A catalase loading level of up to 28% was achieved, and the encapsulated catalase was found to retain up to 58 % of its biological activity.

Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 331: Symposium T – Biomaterials for Drug and Cell Delivery , 1993 , 73
Copyright
Copyright © Materials Research Society 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1) Tomlinson, E., J. Pharm. Pharmacol., 44, 147 (1992).Google Scholar
2) Werb, Z., in Textbook of Rheumatology, 3rd ed., edited by Kelley, W.N., Harris, E.D. Jr., Ruddy, S., and Sledge, C.B. (W.B. Saunders Company, Philadelphia, PA, 1989) pp. 300–319.Google Scholar
3) Azhari, R. and Leong, K., Proceedings of the International Conference on Controlled Release of Bioactive Agents, 18, 617 (1991).Google Scholar
4) Harris, E.D. Jr., and Krane, S.M., Biochimica et Biophysica Acta, 258, 566 (1972).Google Scholar
5) Johnson, T.J.A., in Biocatalyst Design for Stability and Specificity, edited by Himmel, M.H. and Georgiou, G.G. (American Chemical Society Symposium Series, 516, New York, NY, 1991) p. 290.Google Scholar